Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew E. Monaghan currently holds 4,863 shares of Syneos Health, Inc. (SYNH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew E. Monaghan has been a net buyer of SYNH stock. They have purchased $397.7K and sold $29.9K worth of shares.
Matthew E. Monaghan's most recent insider trade was on Sep 28, 2023, when they sold 19,777 shares at $43.00 per share.
Matthew E. Monaghan serves as Executive at Syneos Health, Inc. (SYNH). They have executed 42 insider transactions totaling $427.7K over their tenure at the company.
Matthew E. Monaghan holds the position of Executive at Syneos Health, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Matthew E. Monaghan has shown a buying trading pattern, with $397.7K in total purchases and $29.9K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Matthew E. Monaghan was on Feb 19, 2020, when they sold $1.0M worth of IVC shares. This transaction involved 116,381 shares at $8.72 per share.
Matthew E. Monaghan currently owns 4,863 shares of Syneos Health, Inc. (SYNH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew E. Monaghan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew E. Monaghan has 42 Form 4 filings on record as an insider at Syneos Health, Inc..
Set alerts for Matthew E. Monaghan and 40,000+ other insiders.